For help on how to get the results you want, see our search tips.
279 results
Medicine
Summaries of opinion Remove Summaries of opinion filter
Orphan designations Remove Orphan designations filter
Medicine type
Additional monitoring Remove Additional monitoring filter
Orphan medicine Remove Orphan medicine filter
Biosimilar Remove Biosimilar filter
Categories
Human Remove Human filter
-
List item
Orphan designation: Human heterologous liver cells for: Treatment of ornithine-transcarbamylase deficiency
Date of designation: 14/09/2007, Positive, Last updated: 16/08/2016 -
List item
Orphan designation: Rubitecan for: Treatment of pancreatic cancer
Date of designation: 10/06/2003, Positive, Last updated: 23/06/2003 -
List item
Orphan designation: (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone for: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Date of designation: 28/10/2005, Positive, Last updated: 12/10/2018 -
List item
Orphan designation: Pralatrexate for: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Date of designation: 13/04/2007, Positive, Last updated: 07/04/2011 -
List item
Orphan designation: Sodium benzoate for: Treatment of citrullinaemia type 1
Date of designation: 14/07/2016, Positive, Last updated: 06/09/2016 -
List item
Orphan designation: Sodium benzoate for: Treatment of argininosuccinic aciduria
Date of designation: 18/11/2016, Positive, Last updated: 14/12/2016 -
List item
Orphan designation: Deferiprone for: Treatment of neurodegeneration with brain iron accumulation
Date of designation: 27/06/2018, Positive, Last updated: 04/02/2020 -
List item
Orphan designation: RNA, [P-deoxy-P-(dimethylamino)] (2',3'-dideoxy-2',3'-imino-2',3'-seco) (2'a→5') (C-m5U-C-C-A-A-C-A-m5U-C-A-A-G-G-A-A-G-A-m5U-G-G-C-A-m5U-m5U-m5U-C-m5U-A-G), P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N dimethylaminophosphonamidate (Eteplirsen) for: Treatment of Duchenne muscular dystrophy
Date of designation: 03/12/2008, Positive, Last updated: 22/01/2019 -
List item
Orphan designation: Eflornithine for: Treatment of familial adenomatous polyposis (FAP)
Date of designation: 24/01/2013, Positive, Last updated: 29/04/2019 -
List item
Orphan designation: Human heterologous liver cells for: Treatment of citrullinaemia type 1
Date of designation: 08/10/2009, Positive, Last updated: 16/08/2016 -
List item
Orphan designation: Sodium benzoate for: Treatment of ornithine transcarbamylase deficiency
Date of designation: 14/07/2016, Positive, Last updated: 06/09/2016 -
List item
Orphan designation: Masitinib mesilate for: Treatment of amyotrophic lateral sclerosis
Date of designation: 29/08/2016, Positive, Last updated: 03/10/2016 -
List item
Orphan designation: N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole for: Treatment of mastocytosis
Date of designation: 16/11/2004, Positive, Last updated: 27/10/2005 -
List item
Orphan designation: Alpha-1 antitrypsin for: Treatment of emphysema secondary to congenital alpha-1 antitrypsin deficiency
Date of designation: 16/11/2004, Positive, Last updated: 07/05/2019 -
List item
Orphan designation: Benzoic acid, sodium salt for: Treatment of non-ketotic hyperglycinaemia
Date of designation: 11/09/2002, Positive, Last updated: 08/01/2003 -
List item
Orphan designation: Sodium benzoate for: Treatment of N-acetylglutamate synthetase (NAGS) deficiency
Date of designation: 18/11/2016, Positive, Last updated: 14/12/2016 -
List item
Orphan designation: (-)-17(Cyclopropylmethyl)-1,14 beta-dihydroxy-4,5 alpha-epoxy-6beta-[N-methyl-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (nalfurafine) for: Treatment of uraemic pruritus
Date of designation: 11/09/2002, Positive, Last updated: 14/02/2017 -
List item
Orphan designation: Beclomethasone 17, 21-dipropionate for: Treatment of intestinal graft-versus-host disease
Date of designation: 13/03/2002, Positive, Last updated: 08/06/2020 -
List item
Orphan designation: Autologous tumour-derived immunoglobulin idiotype coupled to keyhole limpet hemocyanin for: Treatment of follicular lymphoma
Date of designation: 28/08/2006, Positive, Last updated: 14/06/2012 -
List item
Orphan designation: edaravone for: Treatment of amyotrophic lateral sclerosis
Date of designation: 19/06/2015, Positive, Last updated: 21/05/2019 -
List item
Orphan designation: Murine monoclonal antibody against CD26 for: Treatment of graft-versus-host disease
Date of designation: 26/11/2010, Positive, Last updated: 22/01/2014 -
List item
Orphan designation: Human heterologous liver cells for: Treatment of hyperargininaemia
Date of designation: 17/12/2010, Positive, Last updated: 16/08/2016 -
List item
Orphan designation: Adenoviral vector containing human p53 gene for: Treatment of Li Fraumeni Syndrome
Date of designation: 23/10/2006, Positive, Last updated: 02/04/2009 -
List item
Orphan designation: Sodium benzoate for: Treatment of ornithine translocase deficiency
Date of designation: 29/08/2016, Positive, Last updated: 03/10/2016 -
List item
Orphan designation: 27000 for: Treatment of post-polycythaemia vera myelofibrosis
Date of designation: 25/08/2010, Positive, Last updated: 29/03/2016